Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TrEatment Targets in Rheumatoid Arthritis: a Randomized Multi-centre, Treat to Target Strategy Trial: TETRA Study

NCT06046950 is registered in ClinicalTrials.gov with Sint Maartenskliniek as lead sponsor.

NCT NCT06046950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TrEatment Targets in Rheumatoid Arthritis: a Randomized Multi-centre, Treat to Target Strategy Trial: TETRA Study
Lead sponsor
Sint Maartenskliniek
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 20, 2023
Completion date
February 28, 2027
Enrollment
340 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis